QIAGEN powered by

Human Gene Mutation Database (HGMD) Professional

Solve more cases faster, with data you can trust using HGMD Professional, the de facto standard resource for identifying inherited disease-causing mutations

Leave no stone unturned

When a family has a child with a rare undiagnosed condition or a couple is planning their next chapter, they want assurance that their doctors are considering every peer-reviewed paper and all available evidence in their quest for an answer.

HGMD Professional remains the largest, manually curated resource for finding disease-causing mutations. Founded and maintained by the Institute of Medical Genetics at Cardiff University, the database attempts to collate all known (published) gene lesions responsible for human inherited disease, giving you the best possible chance of reaching a diagnosis.

Discover more disease-causing mutations

Empower your clinical research and testing with the world’s largest database of inherited human mutations

282,895

detailed mutation reports

All data is based on published, peer-reviewed literature that has been manually curated and evaluated for accuracy.

30,000+

new mutation reports per year

Every quarter, HGMD Professional content and functionality is updated to ensure you remain informed on the latest findings.

10,500+

detailed summary reports

For certain mutations, HGMD Professional includes summaries of disease-associated/functional polymorphisms. 

View the complete HGMD Professional database statistics here.

See what’s new in the latest HGMD Professional release (2020.1) here.

“QIAGEN’s HGMD provides us with access to curated, peer-reviewed evidence that will support more precise, comprehensive variant interpretation. Pairing that with QIAGEN’s automated and scalable informatics framework facilitates our day-to-day secondary and tertiary bioinformatics analyses, and will help improve the quality of care for patients.”

Stan Letovsky, PhD
Vice President of Data Sciences and Bioinformatics at LabCorp

Expert-curated content updated quarterly to keep your current

HGMD is powered by a team of expert curators at Cardiff University. Data are collected weekly by a combination of manual and computerized search procedures. In excess of 250 journals are scanned for articles describing germline mutations causing human genetic disease. The required data are extracted from the original articles and augmented with the necessary supporting data.

The number of disease-associated germline mutations published per year has more than doubled in the past decade (Figure 1). As rare and novel genetic mutations continue to be uncovered, having access to the latest scientific evidence is critical for timely interpretations of next-generation sequencing (NGS) data.

Figure 1. Mutation entries in HGMD Professional. The number of  germline mutations published per year has more than doubled since 2010.

Read now: “HGMD and ClinVar: Avoiding the Knowledge Blind Spot
How HGMD Enables Better Care with Better Knowledge”

White paper

Avoid the knowledge blind spot

In 2008, Christian Millare had a severe seizure and died. He was two years old. His mother was convinced that based on his medical records, the opinions of experts, and the published literature, her son’s life didn’t have to come to such a premature end. 

And she was right. In 2017, Christian had a battery of tests, including the sequencing of the SCN1A gene. The lab that performed this genetic test reported that he had a variant of unknown significance (VUS) there. 

However, that same SCN1A mutation had been identified in an Australian family in 2006. The lab had failed to find the one publication that could have saved Christian’s live. 

On-demand webinar

Empowering a generation of geneticists for precision medicine

Hear from Peter Stensen, a research associate at the Institute of Medical Genetics at Cardiff University and a founder of HGMD, as he shares how the database has grown over the years and the research it has enabled. 

In this on-demand webinar, you will learn how HGMD has helped move precision medicine forward by providing translational research and diagnostic applications with the most comprehensive survey of literature on genetic mutations responsible for human inherited diseases.

Technical note

Using HGMD mutation data with popular variant annotation tools

Numerous free or open source variant annotation tools are available today to extract, annotate and analyze the genomes and their identified variants coming from NGS methods.

However, the value derived from variant annotation is directly related to the information resource selected for annotation. In this technical note, we provide a guide for using HGMD data with three tools: ANNOVAR, snpEff, and VariantAnnotation (Bioconductor).

Why you should upgrade to HGMD Professional​

If you currently use the public version of HGMD, there is a lot of content that you are missing.  Not only is the public version of the database three years behind in terms of published mutation entries, it lacks a multitude of search features critical to elucidating clinically significant associations.

For example, only in HGMD Professional can you search for a mutation by chromosome location, gene ontology or phenotype. But that’s not all. See the full comparison between the public and professional versions of HGMD below.

Expanding into clinical test reporting?

For clinical labs looking to expand into hereditary disease testing, QIAGEN Clinical Insight (QCI) Interpret reproducibly translates highly complex NGS data into standardized reports using current clinical evidence from the QIAGEN Knowledge Base, which consists of over 40 public and proprietary databases, including HGMD Professional.

QCI Interpret for Hereditary Diseases delivers manually curated evidence directly to your pipeline. You receive links to all articles, auto-computed ACMG/AMP classifications, and access to over 1 million unpublished variant-phenotype relationships from the QIAGEN Knowledge Base.

QCI Hereditary Disease applications:
  • Hereditary cancer 
  • Inherited disorders 
  • Rare and undiagnosed diseases 
  • Whole exome sequencing (WES)
  • Whole genome sequencing (WGS)

Request a free trial
of HGMD

Discover the difference of HGMD Professional with a free, no-obligation trial of the industry-leading database.

QCI Interpret

Expand your clinical interpretation with expert-curated software for variant classification of any assay, covering any indication, on your sequencing platform

QCI Precision Insights

Reimagine your clinical interpretation with same day, expert variant classification services tailored to your oncology panel

Clinical Analysis and Interpretation Services

Leverage the benefits of automation and expert support to improve test turnaround times and clinical reporting capabilities